← Back to Search

AI Assistance for Cognitive Overload

N/A

Waitlist Available

Led By Shivani Sud

Research Sponsored by UNC Lineberger Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

1. The subject is a physician, medical student, or postdoctoral student.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 2 hours

Awards & highlights

Study Summary

This trial will study how AI can help reduce the mental load for physicians when writing up medical cases. It'll last two hours and explore two rare cases.

Who is the study for?

This trial is for physicians, medical students, or postdoctoral students. It's designed to see if AI can help reduce the mental effort they use when writing about rare tumor cases.Check my eligibility

What is being tested?

The study tests whether artificial intelligence (AI) assistance can ease cognitive workload during the preparation and submission of case reports on rare tumors by comparing report writing with and without AI help.See study design

What are the potential side effects?

Since this trial involves using an AI tool for writing assistance rather than a medical intervention, there are no direct physical side effects expected from participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 2 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 2 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 2 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Perceived cognitive load

Subjective Cognitive workload (CWL)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Case Report with Artificial IntelligenceExperimental Treatment1 Intervention

Medical students, resident physicians, or attending physicians report rare cases with using Artificial Intelligence.

Group II: Case Report without Artificial IntelligenceActive Control1 Intervention

Medical students, resident physicians, or attending physicians report rare cases without using Artificial Intelligence.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Artificial Intelligence

2021

N/A

~1800

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

UNC Lineberger Comprehensive Cancer CenterLead Sponsor

351 Previous Clinical Trials

88,323 Total Patients Enrolled

Shivani SudPrincipal InvestigatorUNC Lineberger Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open enrollment periods for this research study?

"According to clinicaltrials.gov, this trial is not enrolling participants at the present moment. The study was initially made public on September 1st 2023 and last edited on August 29th 2023. There are nonetheless 1 other medical studies that are presently looking for volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluation of Impact of AI Assistance on Workload Associated w Preparation of Rare Tumor Case Repts

2024. "Evaluation of Impact of AI Assistance on Workload Associated w Preparation of Rare Tumor Case Repts". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06026098.